PerkinElmer, Inc.
Apr 25, 2013
PDF

PerkinElmer Announces Financial Results for the First Quarter of 2013

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the first quarter ended March 31, 2013.

The Company reported GAAP earnings per share from continuing operations of $0.28, compared to $0.19 in the first quarter of 2012. Revenue in the first quarter of 2013 was $505.4 million, as compared to $510.9 million in the first quarter of 2012. GAAP operating income from continuing operations for the first quarter of 2013 was $35.9 million, compared to $36.4 million income in the first quarter of 2012. GAAP operating profit margin from continuing operations was 7.1% in the first quarter of 2013, compared to 7.1% in the first quarter of 2012.

Adjusted earnings per share was $0.36, compared to $0.43 in the first quarter of 2012. Adjusted revenue for the quarter declined 2% to $507.3 million, compared to $517.4 million in the first quarter of 2012. Organic revenues declined 1% after adjusting for a decrease due to unfavorable foreign currency translations of 1%. Adjusted operating income for the first quarter of 2013 was $63.7 million, compared to $79.0 million for the same period a year ago. Adjusted operating profit margin was 12.6% as a percentage of adjusted revenue, compared to 15.3% for the same period a year ago. For the Company's non-GAAP financial measures, adjustments have been noted in the attached reconciliations.

"The majority of the business delivered solid growth in the quarter despite challenging global economic conditions. However a portion of our portfolio experienced more significant headwinds specifically in Europe and Japan," said Robert Friel, chairman and chief executive officer of PerkinElmer. "As a result, we are adjusting our sales forecast while maintaining the appropriate balance between prudent cost management and our growth and productivity investments."

Cash Flow

For the three months ending March 31, 2013, operating cash flow from continuing operations was $11.1 million as compared to $15.3 million for the same period a year ago. Adjusted operating cash flow from continuing operations was $71.0 million as compared to $33.5 million for the same period a year ago.

Financial Overview by Reporting Segment for the First Quarter 2013

Human Health

Environmental Health

Financial Guidance — Full Year 2013 - Updated

For the full year 2013, the Company forecasts organic revenue to increase in the low-single digit range relative to 2012. For the full year 2013, the Company now forecasts GAAP earnings per share from continuing operations in the range of $1.30 to $1.40 and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share in the range of $2.00 to $2.10.

Conference Call Information

The Company will discuss its first quarter results and its outlook for business trends in a conference call on April 25, 2013 at 5:00 p.m. Eastern Time (ET). To access the call, please dial (617) 399-5129 prior to the scheduled conference call time and provide the access code 43039013. A playback of this conference call will be available beginning 7:00 p.m. ET, Thursday, April 25, 2013. The playback phone number is (617) 801-6888 and the code number is 60723454.

A live audio webcast of the call will be available on the Investor section of the Company's Web site, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary software. An archived version of the webcast will be posted on the Company's Web site for a two week period beginning approximately two hours after the call.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) our ability to realize the full value of our intangible assets; (21) significant fluctuations in our stock price; (22) reduction or elimination of dividends on our common stock; and (23) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

 

PerkinElmer, Inc. and Subsidiaries

CONSOLIDATED INCOME STATEMENTS
 
 
 

Three Months Ended

(In thousands, except share and per share data)

March 31, 2013

 

April 1, 2012

 
 
Revenue $ 505,378 $ 510,890
 
Cost of revenue 280,493 278,876
Research and development expenses 34,177 32,624
Selling, general and administrative expenses 151,497 156,849
Restructuring and contract termination charges, net   3,310     6,159  
 
Operating income from continuing operations 35,901 36,382
 
Interest income (105 ) (210 )
Interest expense 11,693 11,437
Other expense   452     1,603  
 
Income from continuing operations before income taxes 23,861 23,552
 
(Benefit from) provision for income taxes   (8,428 )   1,476  
 
Income from continuing operations 32,289 22,076
 
(Loss) gain on disposition of discontinued operations, before income taxes (92 ) 535
(Benefit from) provision for income taxes on discontinued operations and dispositions   (19 )   42  
 
(Loss) income from discontinued operations and dispositions (73 ) 493
 
Net income $ 32,216   $ 22,569  
 
 
Diluted earnings (loss) per share:
Income from continuing operations $ 0.28 $ 0.19
 
(Loss) income from discontinued operations and dispositions   (0.00 )   0.00  
 
Net income $ 0.28   $ 0.20  
 
 
Weighted average diluted shares of common stock outstanding 114,716 114,119
 
 
ABOVE PREPARED IN ACCORDANCE WITH GAAP
 
         
Additional Supplemental Information:
(per share, continuing operations)
 
GAAP EPS from continuing operations $ 0.28 $ 0.19
Amortization of intangible assets, net of income taxes 0.13 0.13
Purchase accounting adjustments, net of income taxes 0.01 0.06
Acquisition-related costs, net of income taxes 0.00 0.00
Mark to market on post-retirement benefits, net of income taxes (0.00 ) 0.01
Significant tax credits (0.08 ) -
Restructuring and contract termination charges, net of income taxes   0.02     0.04  
Adjusted EPS $ 0.36   $ 0.43  
                 
 

 
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
     
 
 

Three Months Ended

(In thousands, except percentages)

March 31, 2013

April 1, 2012

(as adjusted)
 
Human Health Revenue $ 281,329 $ 280,778
Purchase accounting adjustments 1,932   6,473  
Adjusted revenue 283,261   287,251  
 
Operating income 25,020 18,211
OP% 8.9 % 6.5 %
Amortization of intangible assets 20,026 20,816
Purchase accounting adjustments 1,980 11,547
Acquisition-related costs 22 176
Restructuring and contract termination charges, net 3,238   4,941  
Adjusted operating income $ 50,286   $ 55,691  
Adjusted OP% 17.8 % 19.4 %
 
Environmental Health Revenue $ 224,049 $ 230,112
 
Operating income 20,728 30,129
OP% 9.3 % 13.1 %
Amortization of intangible assets 2,462 2,583
Acquisition-related costs 49 75
Restructuring and contract termination charges, net 72   1,218  
Adjusted operating income $ 23,311   $ 34,005  
Adjusted OP% 10.4 % 14.8 %
 
Corporate Operating loss $ (9,847 ) $ (11,958 )
Mark to market on post-retirement benefits (47 ) 1,219  
Adjusted operating loss $ (9,894 ) $ (10,739 )
 
 
Continuing Operations Revenue $ 505,378 $ 510,890
Purchase accounting adjustments 1,932   6,473  
Adjusted revenue 507,310   517,363  
 
Operating income 35,901 36,382
OP% 7.1 % 7.1 %
Amortization of intangible assets 22,488 23,399
Purchase accounting adjustments 1,980 11,547
Acquisition-related costs 71 251
Mark to market on post-retirement benefits (47 ) 1,219
Restructuring and contract termination charges, net 3,310   6,159  
Adjusted operating income $ 63,703   $ 78,957  
Adjusted OP% 12.6 % 15.3 %
 
 
REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
 

 
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
   
 

Three Months Ended

March 31, 2013

April 1, 2012

(In thousands)
 
Operating activities:
Net income $ 32,216 $ 22,569

Less: loss (income) from discontinued operations and dispositions, net of income taxes

  73     (493 )
Income from continuing operations   32,289     22,076  

Adjustments to reconcile income from continuing operations

to net cash provided by continuing operations:
Stock-based compensation 4,416 5,476
Restructuring and contract termination charges, net 3,310 6,159
Amortization of deferred debt issuance costs, interest rate hedge and accretion of discounts 813 867
Depreciation and amortization 30,571 32,007
Amortization of acquired inventory revaluation 129 4,495
Changes in operating assets and liabilities which provided (used) cash, excluding
effects from companies purchased and divested:
Accounts receivable, net 40,227 5,850
Inventories, net (16,187 ) (12,970 )
Accounts payable 4,941 (11,719 )
Accrued expenses and other   (89,391 )   (36,981 )
Net cash provided by operating activities of continuing operations   11,118     15,260  
Net cash (used in) provided by operating activities of discontinued operations   (187 )   279  
Net cash provided by operating activities   10,931     15,539  
 
Investing activities:
Capital expenditures (11,829 ) (5,228 )
Activity related to acquisitions and investments, net of cash and cash equivalents acquired   1,400     -  
Net cash used in investing activities of continuing operations   (10,429 )   (5,228 )
Net cash provided by investing activities of discontinued operations   123     -  
Net cash used in investing activities   (10,306 )   (5,228 )
 
Financing Activities:
Payments on revolving credit facility (135,000 ) (122,000 )
Proceeds from revolving credit facility 213,000 111,000
Payments of debt issuance costs - (279 )
Settlement of cash flow hedges 840 -

Net proceeds from other credit facilities

8,022 -
Excess tax benefit from exercise of common stock options - 1,139
Proceeds from issuance of common stock under stock plans 5,462 9,499
Purchases of common stock (126,858 ) (1,632 )
Dividends paid   (8,060 )   (7,922 )
Net cash used in financing activities   (42,594 )   (10,195 )
 
Effect of exchange rate changes on cash and cash equivalents   (3,604 )   2,299  
 
Net (decrease) increase in cash and cash equivalents (45,573 ) 2,415
Cash and cash equivalents at beginning of period   171,444     142,342  
Cash and cash equivalents at end of period $ 125,871   $ 144,757  
 
 
 
PREPARED IN ACCORDANCE WITH GAAP
 

 
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED BALANCE SHEETS
   
 
 
(In thousands)

March 31, 2013

December 30, 2012

 
 
Current assets:
Cash and cash equivalents $ 125,871 $ 171,444
Accounts receivable, net 410,782 457,011
Inventories, net 259,762 247,688
Other current assets   100,277     95,611  
Total current assets   896,692     971,754  
 
Property, plant and equipment, net:
At cost 519,173 513,479
Accumulated depreciation   (306,501 )   (302,963 )
Property, plant and equipment, net 212,672 210,516
Marketable securities and investments 1,180 1,149
Intangible assets, net 506,540 529,901
Goodwill 2,111,621 2,122,788
Other assets, net   79,441     65,654  
Total assets $ 3,808,146   $ 3,901,762  
 
Current liabilities:
Short-term debt $ 7,301 $ 1,772
Accounts payable 172,166 168,943
Accrued restructuring 17,866 21,364
Accrued expenses and other current liabilities 375,156 388,026
Current liabilities of discontinued operations   865     995  
Total current liabilities   573,354     581,100  
 
Long-term debt 1,019,345 938,824
Accrued restructuring 5,789 6,387
Long-term liabilities   375,235     435,639  
Total liabilities   1,973,723     1,961,950  
 
Total stockholders' equity   1,834,423     1,939,812  
Total liabilities and stockholders' equity $ 3,808,146   $ 3,901,762  
 
 
PREPARED IN ACCORDANCE WITH GAAP
 

 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
               
(In millions, except per share data and percentages) PKI
Three Months Ended

March 31, 2013

   

April 1, 2012

 
 
Adjusted revenue:
Revenue $ 505.4 $ 510.9
Purchase accounting adjustments   1.9           6.5      
Adjusted revenue $ 507.3         $ 517.4      
 
Adjusted gross margin:
Gross margin $ 224.9 44.5 % $ 232.0 45.4 %
Amortization of intangible assets 12.9 2.5 % 13.0 2.5 %
Purchase accounting adjustments 2.1 0.4 % 11.0 2.1 %

Mark to market on post-retirement benefits

  (0.0 )   0.0 %     1.2     0.2 %
Adjusted gross margin $ 239.8     47.3 %   $ 257.2     49.7 %
 
Adjusted SG&A:
SG&A $ 151.5 30.0 % $ 156.8 30.7 %
Amortization of intangible assets (9.6 ) -1.9 % (10.3 ) -2.0 %
Purchase accounting adjustments 0.1 0.0 % (0.6 ) -0.1 %
Acquisition-related costs   (0.1 )   0.0 %     (0.3 )   0.0 %
Adjusted SG&A $ 141.9     28.0 %   $ 145.7     28.2 %
 
Adjusted R&D:
R&D $ 34.2 6.8 % $ 32.6 6.4 %
Amortization of intangible assets   (0.1 )   0.0 %     (0.1 )   0.0 %
Adjusted R&D $ 34.1     6.7 %   $ 32.5     6.3 %
 
Adjusted operating income:
Operating income $ 35.9 7.1 % $ 36.4 7.1 %
Amortization of intangible assets 22.5 4.4 % 23.4 4.6 %
Purchase accounting adjustments 2.0 0.4 % 11.5 2.3 %
Acquisition-related costs 0.1 0.0 % 0.3 0.0 %

Mark to market on post-retirement benefits

(0.0 ) 0.0 % 1.2 0.2 %
Restructuring and contract termination charges, net   3.3     0.7 %     6.2     1.2 %
Adjusted operating income $ 63.7     12.6 %   $ 79.0     15.3 %
             
PKI
Three Months Ended

March 31, 2013

April 1, 2012

 
Adjusted EPS:
EPS $ 0.28 $ 0.20
Discontinued operations, net of income taxes   (0.00 )         0.00      
EPS from continuing operations 0.28 0.19
Amortization of intangible assets, net of income taxes 0.13 0.13
Purchase accounting adjustments, net of income taxes 0.01 0.06
Acquisition-related costs, net of income taxes 0.00 0.00

Mark to market on post-retirement benefits, net of income taxes

(0.00 ) 0.01
Significant tax credits (0.08 ) -
Restructuring and contract termination charges, net of income taxes   0.02           0.04      
Adjusted EPS $ 0.36         $ 0.43      
             
PKI
Three Months Ended

March 31, 2013

April 1, 2012

Adjusted operating cash flow:
Net cash provided by operating activities of continuing operations $ 11.1 $ 15.3

Significant contributions to post-retirement plans

47.0 17.0
Significant prepaid royalty payments 12.9 -

Excess tax benefit from exercise of common stock options

  -           1.2      
Adjusted operating cash flow   71.0           33.5      
             
PKI
Twelve Months Ended

December 29, 2013

Adjusted EPS: Projected
EPS from continuing operations $ 1.30 - 1.40
Amortization of intangible assets, net of income taxes 0.51
Purchase accounting adjustments, net of income taxes 0.05
Restructuring and contract termination charges, net of income taxes 0.22
Significant tax credits           (0.08 )    
Adjusted EPS         $ 2.00 - 2.10      
             
Human Health
Three Months Ended

March 31, 2013

April 1, 2012

(As adjusted)
Adjusted revenue:
Revenue $ 281.3 $ 280.8
Purchase accounting adjustments   1.9           6.5      
Adjusted revenue $ 283.3         $ 287.3      
 
Adjusted operating income:
Operating income $ 25.0 8.9 % $ 18.2 6.5 %
Amortization of intangible assets 20.0 7.1 % 20.8 7.4 %
Purchase accounting adjustments 2.0 0.7 % 11.5 4.1 %
Acquisition-related costs 0.0 0.0 % 0.2 0.1 %
Restructuring and contract termination charges, net   3.2     1.2 %     4.9     1.8 %
Adjusted operating income $ 50.3     17.8 %   $ 55.7     19.4 %
             
Environmental Health
Three Months Ended

March 31, 2013

April 1, 2012

(As adjusted)
 
Revenue $ 224.0 $ 230.1
 
Adjusted operating income:
Operating income $ 20.7 9.3 % $ 30.1 13.1 %
Amortization of intangible assets 2.5 1.1 % 2.6 1.1 %
Acquisition-related costs 0.0 0.0 % 0.1 0.0 %
Restructuring and contract termination charges, net   0.1     0.0 %     1.2     0.5 %
Adjusted operating income $ 23.3     10.4 %   $ 34.0     14.8 %
 

 
PerkinElmer, Inc. and Subsidiaries
Q1 2013 Organic Revenue Growth
 
 
PKI
Three Months Ended

March 31, 2013

Organic revenue growth:
Reported revenue growth -1%
Less: effect of purchase accounting adjustments 1%
Adjusted revenue growth -2%
Less: effect of foreign exchange rates -1%
Less: effect of acquisitions 0%
Organic revenue growth -1%
 
 
Human Health
Three Months Ended

March 31, 2013

Organic revenue growth:
Reported revenue growth 0%
Less: effect of purchase accounting adjustments 2%
Adjusted revenue growth -1%
Less: effect of foreign exchange rates -1%
Less: effect of acquisitions 0%
Organic revenue growth 0%
 
 
Environmental Health
Three Months Ended

March 31, 2013

Organic revenue growth:
Reported revenue growth -3%
Less: effect of foreign exchange rates -1%
Less: effect of acquisitions 0%
Organic revenue growth -1%
 

Adjusted Revenue and Adjusted Revenue Growth

We use the term "adjusted revenue" to refer to GAAP revenue, including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term "adjusted revenue growth" to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate long-term performance trends and to assess our ability to invest in our business. Adjusted revenue growth also provides for easier comparisons of our performance with prior and future periods and relative comparisons to our peers. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Organic Revenue and Organic Revenue Growth

We use the term "organic revenue" to refer to GAAP revenue, excluding the effect of foreign currency translation and acquisitions, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term "organic revenue growth" to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate long-term performance trends and to assess our ability to invest in our business. Organic revenue growth also provides for easier comparisons of our performance with prior and future periods and relative comparisons to our peers. We exclude the effect of foreign currency translation from these measures because foreign currency translation is subject to volatility and can obscure underlying trends. We exclude the effect of acquisitions because acquisition activity can vary dramatically between reporting periods and between us and our peers, which we believe makes comparisons of long-term performance trends difficult for management and investors, and could result in overstating or understating to our investors the performance of our operations. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Gross Margin and Adjusted Gross Margin Percentage

We use the term "adjusted gross margin" to refer to GAAP gross margin, excluding amortization of intangible assets, inventory fair value adjustments related to business acquisitions, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We use the related term "adjusted gross margin percentage" to refer to adjusted gross margin as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate the long-term profitability trends and to assess our ability to invest in our business. We exclude amortization of intangible assets from these measures because intangibles amortization charges do not represent what we believe our investors consider to be costs of producing our products and could distort the additional value generated over the cost of producing those products. In addition, inventory fair value adjustments related to business acquisitions and adjustments for mark-to-market accounting on post-retirement benefits do not represent what we believe our investors consider to be costs used in producing our products. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Selling, General and Administrative ("SG&A") Expense and Adjusted SG&A Percentage

We use the term "adjusted SG&A expense" to refer to GAAP SG&A expense, excluding amortization of intangible assets, changes to the fair values assigned to contingent consideration, and other costs related to business acquisitions. We use the related term "adjusted SG&A percentage" to refer to adjusted SG&A expense as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the cost of the internal operating structure, our ability to leverage that structure and the level of investment required to grow our business. We exclude amortization of intangible assets from these measures because intangibles amortization charges do not represent what we believe our investors consider to be costs that support our internal operating structure and could distort the efficiencies of that structure. We exclude changes to the fair values assigned to contingent consideration, and other costs related to business acquisitions, because they only occur due to an acquisition and the potential subsequent repositioning of the business that could distort the performance measures of costs to support our internal operating structure.

Adjusted Research and Development ("R&D") Expense and Adjusted R&D Percentage

We use the term "adjusted R&D expense" to refer to GAAP R&D expense, excluding amortization of intangible assets. We use the related term "adjusted R&D percentage" to refer to adjusted R&D expense as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better understand and evaluate our internal technology investments. We exclude amortization of intangible assets from these measures because intangibles amortization charges do not represent what we believe our investors consider to be internal investments in R&D activities and could distort our R&D investment level.

Adjusted Operating Income, Adjusted Operating Profit Percentage, Adjusted Operating Profit Margin and Adjusted Operating Margin

We use the term "adjusted operating income," to refer to GAAP operating income, excluding amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, and restructuring and contract termination charges, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. Adjusted operating income is calculated by subtracting adjusted R&D expense and adjusted SG&A expense from adjusted gross margin. We use the related terms "adjusted operating profit percentage," "adjusted operating profit margin," or "adjusted operating margin" to refer to adjusted operating income as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to analyze the costs of the different components of producing and selling our products, to better measure the performance of our internal investments in technology and to evaluate the long-term profitability trends of our core operations. Adjusted operating income also provides for easier comparisons of our performance and profitability with prior and future periods and relative comparisons to our peers. We believe our investors do not consider the items that we exclude from adjusted operating income to be costs of producing our products, investments in technology and production or costs to support our internal operating structure, and so we present this non-GAAP measure to avoid overstating or understating to our investors the performance of our operations. We exclude restructuring and contract termination charges because they tend to occur due to an acquisition, divestiture, repositioning of the business or other unusual event that could distort the performance measures of our internal investments and costs to support our internal operating structure. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Earnings Per Share

We use the term "adjusted earnings per share," or "adjusted EPS," to refer to GAAP earnings per share, excluding discontinued operations, amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, restructuring and contract termination charges, and significant tax credits, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. Adjusted earnings per share is calculated by subtracting the items above included in adjusted gross margin, adjusted R&D expense, adjusted SG&A expense, restructuring and contract termination charges, the provision for taxes related to these items, and significant tax credits from GAAP earnings per share. We believe that this non-GAAP measure, when taken together with our GAAP financial measures, allows us and our investors to analyze the costs of producing and selling our products and the performance of our internal investments in technology and our internal operating structure, to evaluate the long-term profitability trends of our core operations and to calculate the underlying value of the core business on a dilutive share basis, which is a key measure of the value of the Company used by our management and we believe used by investors as well. Adjusted earnings per share also facilitates the overall analysis of the value of the Company and the core measure of the success of our operating business model as compared to prior and future periods and relative comparisons to our peers. We exclude discontinued operations, amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, adjustments for mark-to-market accounting on post-retirement benefits, restructuring and contract termination charges, and significant tax credits, as these items do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure, which could result in overstating or understating to our investors the performance of our operations. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

The first quarter tax effect on adjusted EPS for (i) discontinued operations was a benefit of $0.00 in 2013 and an expense of $0.00 in 2012, (ii) amortization of intangible assets was an expense of $0.07 in both 2013 and 2012, (iii) inventory fair value adjustments related to business acquisitions was an expense of $0.00 in 2013 and an expense of $0.01 in 2012, (iv) restructuring and contract termination charges was an expense of $0.01 in 2013 and an expense of $0.02 in 2012, (v) significant tax credits was a benefit of $0.08 in 2013, (vi) the estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination accounting rules was an expense of $0.01 in 2013 and an expense of $0.02 in 2012. The first quarter tax effect on adjusted EPS for each of the remaining items (changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, and adjustments for mark-to-market accounting on post-retirement benefits) was $0.00 in both 2013 and 2012.

The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board's Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, adjustments for mark-to-market accounting on post-retirement benefits, restructuring and contract termination charges, and significant tax credits, and the estimated revenue from contracts acquired with various acquisitions is calculated based on operational results and applicable jurisdictional law, which contemplates tax rates currently in effect to determine our tax provision.

Adjusted Operating Cash Flow

We use the term "adjusted operating cash flow" to refer to GAAP operating cash flow from continuing operations, excluding the effect of the excess tax benefit from the exercise of equity grants, significant contributions to our post-retirement benefit plans, and significant prepaid royalty payments. We believe that this non-GAAP measure, when taken together with our GAAP financial measure, allows us and our investors to better evaluate the long-term performance trends and to assess our ability to invest in the business. Adjusted operating cash flow also provides for easier comparisons of our performance with prior and future periods and relative comparisons to our peers. We exclude the effect of the excess tax benefit from the exercise of equity grants, significant contributions to our post-retirement benefit plans, and significant prepaid royalty payments from this measure because the excess tax benefit from the exercise of equity grants, significant contributions to our post-retirement benefit plans, and significant prepaid royalty payments can vary dramatically by quarter and between us and our peers and can obscure underlying trends, which we believe makes comparisons of long-term performance trends difficult for management and investors, and could result in overstating or understating to our investors the performance of our operations.

# # #

The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.

Each of the non-GAAP financial measures listed above are also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, CPA, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
stephanie.wasco@perkinelmer.com

Source: PerkinElmer, Inc.

News Provided by Acquire Media